3Hermida RC, Ayala DE, Cairo, et al. Effects of time of day of treatment on ambulatory blood pressure pattern of patients with resistant hypertension [J]. J Hypertension, 2005, 46 (4): 1053.
4Everson-Rose SA, Meyer PM, Powell LH, et al. Insulin resistance and risks of diabetes at midlife [J]. J Diabetes Care, 2005, 28 (5); 1265-1266.
5Bixter BO, Lira W, Hong S, et al. Neuroendocrine response to the insulin tolerance and patient in chronie fatigue syndrome [J].J Psychosom Res, 2004, 56 (4): 419-424.
6Klausen KP,Sharling H,Jensen G,et al. New definition of microalbuminuris in hypertensive subjects [J]. J Hypertension, 2005, 46 (1):33-37.
7Hermida RC, Cairo C, Ayala DE, et al. Decrease on urinary albumin excretion associated with the normalization of noctural blood pressure in hypertensive subjects [J], J Hypertension, 2005, 46 (4):960-968.
8Yusuf S, Hawken S, Ounpus S, et al, Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries [J]. J Lancet, 2004, 364 (9438):937-952.
9Hermida RC, Cairo C, Ayala DE, et al, Administration timedependent effects of valsartan on ambulatory blood pressure in hypertension subjects [J], J Hypertension, 2003, 42 (3): 283-290.
10Hippisley-Cox J, Coupland C. Effect of combinations of drugs on all cause mortality in patients with ischemie heart disease [J]. J BMJ, 2005,330 (7): 1059-1063.
